EPO and Encephalopathy: At this point, as it has previously been stressed out there are no preclinical data showing the neuroprotective effects of EPO in a model of encephalopathy of prematurity, limiting the understanding of the best paradigm to deliver neuroprotection in this population (Fleiss and Gressens, 2019).